Last updated 2026-09-03
- Raised $1M Series B, Aug 2021
- Raised $4.4M Series A led by ARC Innovation Center, Jul 2021
Total raised
$5.4M
Last: Undisclosed Round 2023-08
Stage
Series C
Founded
2017
Headcount
10
HQ
Tel Aviv, Israel
Sector
Health Tech & Life Sciences
About
HAGAR, the developer of GWave, has created a non-invasive continuous glucose monitoring (CGM) technology that utilizes radio frequency (RF) waves to measure blood glucose levels in real time. The technology originated from an accidental discovery by Dr. Gerry Waintraub. The GWave device is designed to be integrated into a smartwatch, providing a painless and convenient way for individuals with diabetes, prediabetes, and those focused on wellness to track their glucose levels. The company has received FDA Breakthrough Device Designation in 2021 and has conducted clinical studies demonstrating the device's accuracy.
Funding history · 2 rounds · $5.4M total
2 events/rounds · $5.4M Total Funding: $5.4M in Private Equity
Aug 2021
B Round
$1.0M
pitchbook.com
Jul 2021
A Round
$4.4M
pitchbook.com
★ ARC Innovation Center★ Columbia Pacific Advisors Opportunistic
Headcount over time
10 employees (2026-09) · 1 point
Offices
Tel Aviv, Israel · HQ / main office
Q&A
- What is GWave's primary product?
- GWave's primary product is a noninvasive glucometer that uses radio frequency waves and proprietary AI algorithms to continuously measure blood glucose levels in real time.
- When was GWave founded?
- GWave was founded in January 2017.
- What is GWave's current employee count?
- GWave currently has 1-10 employees.
- What is the total amount of funding GWave has raised to date?
- GWave has raised a total of $21.1 million USD.
- When was GWave's most recent funding round, and what was its amount?
- GWave's most recent funding round occurred in August 2023, raising $5 million USD.
- Which investor participated in GWave's funding rounds in July and August 2021?
- Columbia Pacific Capital Partners participated in GWave's funding rounds in July and August 2021.
- What is GWave's current funding stage?
- GWave is currently in its Series C funding stage.
- Who are the co-founders of GWave?
- The co-founders of GWave are Bentzi Gruber (Co-founder & Chairman), Guy Zur (Co-founder & CEO), Gerry Waintraub (Co-founder & CTO), and Taire Rubin (Co-founder & VP of Business Development).
- What technologies does GWave utilize in its product?
- GWave utilizes sensing, communications, radio frequency, Bluetooth, artificial intelligence, and cloud technologies in its product.
Team · 8
Bentzi Gruber
Founder · Co-founder & Chairman
Guy Zur
Founder · Co-founder & CEO
Gerry Waintraub
Founder · Co-founder & CTO
Taire Rubin
Founder · Co-founder & VP of Business Development
Maor Zur
COO
Dr. Irl Hirsch
Medical Advisor, US
Dr. Moshe Rubin
Medical Advisor, Israel
Alexander Fleming, M.D.
Medical and Regulatory Advisor, US
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
Direct SalesSubscription-based
Tags
digital-healthcaremedical-devicesnon-invasivedigital-therapeuticsalgorithmsrf-technologyartificial-intelligencealert-systemreal-timemonitoringcloud-basedmobile-applicationsdiabetessensors
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | hagartech.com/ |
|---|
Identifiers & details
| Legal name | HAGAR N.I.G. |
|---|---|
| Founded | 2017-1 |
| Employees (exact) | 10 |
Radar intelligence
Patents
| EPO | 60 |
|---|
Web history (Wayback)
| Domain | hagartech.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|